0
Your cart

Your cart is empty

Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Hi-tech manufacturing industries

Buy Now

White Market Drugs - Big Pharma and the Hidden History of Addiction in America (Hardcover) Loot Price: R756
Discovery Miles 7 560
White Market Drugs - Big Pharma and the Hidden History of Addiction in America (Hardcover): David Herzberg

White Market Drugs - Big Pharma and the Hidden History of Addiction in America (Hardcover)

David Herzberg

 (sign in to rate)
Loot Price R756 Discovery Miles 7 560 | Repayment Terms: R71 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The contemporary opioid crisis is widely seen as new and unprecedented. Not so. It is merely the latest in a long series of drug crises stretching back over a century. In White Market Drugs, David Herzberg explores these crises and the drugs that fueled them, from Bayer's Heroin to Purdue's OxyContin and all the drugs in between: barbiturate "goof balls," amphetamine "thrill pills," the "love drug" Quaalude, and more. As Herzberg argues, the vast majority of American experiences with drugs and addiction have taken place within what he calls "white markets," where the prescription of addictive drugs is legal and medically approved. These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its "drug wars"--until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America's divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets while caring for people with addiction by ensuring them safe, reliable access to medication-assisted treatment. Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century. By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself--ideas that have been failing us catastrophically for over a century.

General

Imprint: University of Chicago Press
Country of origin: United States
Release date: November 2020
Authors: David Herzberg
Dimensions: 229 x 152 x 32mm (L x W x T)
Format: Hardcover - Sewn / Cloth over boards
Pages: 400
ISBN-13: 978-0-226-73188-9
Categories: Books > Medicine > General issues > History of medicine
Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Hi-tech manufacturing industries
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Nursing & ancillary services > Specific disorders & therapies > Addiction & therapy
Promotions
LSN: 0-226-73188-X
Barcode: 9780226731889

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

New Horizons in Natural Compound…
Surya Nandan Meena, Vinod Nandre, … Paperback R3,468 Discovery Miles 34 680
Lessons from COVID-19 - Impact on…
Habil Arturas Kaklauskas, Ajith Abraham, … Paperback R3,237 Discovery Miles 32 370
Novel AI and Data Science Advancements…
Victor Chang, Mohamed Abdel-Basset, … Paperback R2,941 Discovery Miles 29 410
Systems Evolutionary Biology…
Bor-Sen Chen Paperback R3,167 R2,968 Discovery Miles 29 680
Therapeutic Risk Management of Medicines
Stephen J. Mayall, Anjan Swapu Banerjee Hardcover R4,565 Discovery Miles 45 650
Orphan Drugs - Understanding the Rare…
Elizabeth Hernberg-Stahl, Miroslav Reljanović Hardcover R4,210 Discovery Miles 42 100
Computer-Aided Applications in…
Jelena Duris Hardcover R3,335 Discovery Miles 33 350
A Biotech Manager's Handbook - A…
M. O'Neill, M. M. Hopkins Hardcover R3,457 Discovery Miles 34 570
The International Law of Biotechnology…
Matthias Herdegen Hardcover R2,647 Discovery Miles 26 470
Patenting Biotechnical Innovation…
Naomi Hawkins Hardcover R2,853 Discovery Miles 28 530
The International Law of Biotechnology…
Matthias Herdegen Paperback R895 Discovery Miles 8 950
Transcultural Artificial Intelligence…
Irena Papadopoulos, Christina Koulouglioti, … Paperback R3,250 Discovery Miles 32 500

See more

Partners